TABLE OF CONTENTS
|  | | | Volume 107, Issue 5 (757-900)
Published online 21 August 2012
|  | In this issue
 Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Also new today
 Advance online publication
| | Advertisement | | 
4th World Epigenetics Summit (4-6 Dec, London) Unlock the therapeutic potential of epigenetics with the most exciting names in translational epigenetics research. You'll meet & hear from 23 expert speakers, including GSK, Epizyme, Constellation, SGC, Gurdon Institute & UCL. *Special rates are available for those from not-for-profit institutions* www.epigenetics-europe.com | | | | | | | Advertisement | | | | | | | Clinical Studies | Top | | A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme E J A Morris, L E Whitehouse, T Farrell, C Nickerson, J D Thomas, P Quirke, M D Rutter, C Rees, P J Finan, J R Wilkinson and J Patnick Br J Cancer 2012 107: 757-764; advance online publication, July 31, 2012; 10.1038/bjc.2012.331 Abstract | Full Text | | | | Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme S Morris, G Baio, E Kendall, C von Wagner, J Wardle, W Atkin, S P Halloran, G Handley, R F Logan, A Obichere, S Rainbow, S Smith, J Snowball and R Raine Br J Cancer 2012 107: 765-771; advance online publication, August 2, 2012; 10.1038/bjc.2012.303 Abstract | Full Text | | | | Single-visit approach of cervical cancer screening: See and Treat in Indonesia J N I Vet, J L Kooijman, F C Henderson, F M Aziz, G Purwoto, H Susanto, I G D Surya, S Budiningsih, S Cornain, G J Fleuren, J B Trimbos and A A W Peters Br J Cancer 2012 107: 772-777; advance online publication, July 31, 2012; 10.1038/bjc.2012.334 Abstract | Full Text | | | | To be screened or not to be screened? Modeling the consequences of PSA screening for the individual E M Wever, J Hugosson, E A M Heijnsdijk, C H Bangma, G Draisma and H J de Koning Br J Cancer 2012 107: 778-784; advance online publication, July 17, 2012; 10.1038/bjc.2012.317 Abstract | Full Text | | | | Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial T Dell’ Anna, M Signorelli, P Benedetti-Panici, A Maggioni, R Fossati, R Fruscio, R Milani, L Bocciolone, A Buda, C Mangioni, G Scambia, R Angioli, E Campagnutta, R Grassi and F Landoni Br J Cancer 2012 107: 785-792; advance online publication, August 2, 2012; 10.1038/bjc.2012.336 Abstract | Full Text | | | | Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer G Minuti, F Cappuzzo, R Duchnowska, J Jassem, A Fabi, T O’Brien, A D Mendoza, L Landi, W Biernat, B Czartoryska-Arłukowicz, T Jankowski, D Zuziak, J Zok, B Szostakiewicz, M Foszczyńska-Kłoda, A Tempińska-Szałach, E Rossi and M Varella-Garcia Br J Cancer 2012 107: 793-799; advance online publication, July 31, 2012; 10.1038/bjc.2012.335 Abstract | Full Text | | | | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 G C Wishart, C D Bajdik, E Dicks, E Provenzano, M K Schmidt, M Sherman, D C Greenberg, A R Green, K A Gelmon, V-M Kosma, J E Olson, M W Beckmann, R Winqvist, S S Cross, G Severi, D Huntsman, K Pylkäs, I Ellis, T O Nielsen, G Giles, C Blomqvist, P A Fasching, F J Couch, E Rakha, W D Foulkes, F M Blows, L R Bégin, L J van't Veer, M Southey, H Nevanlinna, A Mannermaa, A Cox, M Cheang, L Baglietto, C Caldas, M Garcia-Closas and P D P Pharoah Br J Cancer 2012 107: 800-807; advance online publication, July 31, 2012; 10.1038/bjc.2012.338 Abstract | Full Text | | | | Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium T M Beer, D C Smith, A Hussain, M Alonso, J Wang, M Giurescu, K Roth and Y Wang Br J Cancer 2012 107: 808-813; advance online publication, July 31, 2012; 10.1038/bjc.2012.339 Abstract | Full Text | | | | Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model O Vainas, S Ariad, O Amir, W Mermershtain, V Vainstein, M Kleiman, O Inbar, R Ben-Av, A Mukherjee, S Chan and Z Agur Br J Cancer 2012 107: 814-822; advance online publication, July 19, 2012; 10.1038/bjc.2012.316 Abstract | Full Text | | Translational Therapeutics | Top | | βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer D C Christoph, S Kasper, T C Gauler, C Loesch, M Engelhard, D Theegarten, C Poettgen, R Hepp, A Peglow, H Loewendick, S Welter, G Stamatis, F R Hirsch, M Schuler, W E E Eberhardt and J Wohlschlaeger Br J Cancer 2012 107: 823-830; advance online publication, July 26, 2012; 10.1038/bjc.2012.324 Abstract | Full Text | | Molecular Diagnostics | Top | | Expression of oestrogen receptor β and prognosis of colorectal cancer A Rudolph, C Toth, M Hoffmeister, W Roth, E Herpel, L Jansen, A Marx, H Brenner and J Chang-Claude Br J Cancer 2012 107: 831-839; advance online publication, July 24, 2012; 10.1038/bjc.2012.323 Abstract | Full Text | | | | Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response J W Thoms, A Dal Pra, P H Anborgh, E Christensen, N Fleshner, C Menard, K Chadwick, M Milosevic, C Catton, M Pintilie, A F Chambers and R G Bristow Br J Cancer 2012 107: 840-846; advance online publication, August 7, 2012; 10.1038/bjc.2012.345 Abstract | Full Text | | | | Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells I Tsaur, J Makarević, E Juengel, M Gasser, A-M Waaga-Gasser, M Kurosch, M Reiter, S Wedel, G Bartsch, A Haferkamp, C Wiesner and R A Blaheta Br J Cancer 2012 107: 847-855; advance online publication, July 10, 2012; 10.1038/bjc.2012.313 Abstract | Full Text | | | | Expression and prognostic significance of Src family members in renal clear cell carcinoma T Qayyum, P A McArdle, G W Lamb, F Jordan, C Orange, M Seywright, P G Horgan, R J Jones, G Oades, M A Aitchison and J Edwards Br J Cancer 2012 107: 856-863; advance online publication, July 19, 2012; 10.1038/bjc.2012.314 Abstract | Full Text | | | | The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer Z MA Mohammed, J J Going, J Edwards, B Elsberger, J C Doughty and D C McMillan Br J Cancer 2012 107: 864-873; advance online publication, August 9, 2012; 10.1038/bjc.2012.347 Abstract | Full Text | | Epidemiology | Top | | Coffee and black tea consumption and breast cancer mortality in a cohort of Swedish women H R Harris, L Bergkvist and A Wolk Br J Cancer 2012 107: 874-878; advance online publication, July 26, 2012; 10.1038/bjc.2012.337 Abstract | Full Text | | | | Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study M E Kroll, F Murphy, K Pirie, G K Reeves, J Green and V Beral for the Million Women Study Collaborators Br J Cancer 2012 107: 879-887; advance online publication, August 9, 2012; 10.1038/bjc.2012.333 Abstract | Full Text | | | | Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit D Nasrollahzadeh, R Malekzadeh, K Aghcheli, M Sotoudeh, S Merat, F Islami, F Kamangar, C C Abnet, R Shakeri, A Pourshams, S Semnani, P Boffetta, S M Dawsey and W Ye Br J Cancer 2012 107: 888-894; advance online publication, July 19, 2012; 10.1038/bjc.2012.332 Abstract | Full Text | | | | Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study B Julin, A Wolk, J-E Johansson, S-O Andersson, O Andrén and A Åkesson Br J Cancer 2012 107: 895-900; advance online publication, July 31, 2012; 10.1038/bjc.2012.311 Abstract | Full Text | | | | | | | Advertisement | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment